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1. Introduction
Green £uorescent protein (GFP) from the jelly¢sh Aequorea
victoria is a single peptide of 238 amino acids [1]. Aequorea
bioluminescence is ¢rst activated when Ca2 binds to aequor-
in following emission of blue £uorescence. Blue £uorescence
and subsequent energy transfer from activated aequorin cause
GFP to emit green £uorescence. Therefore, unlike enzymes,
GFP needs no substrate to emit £uorescence. Rather, it re-
quires only energy to excite the £uorophore. The £uorophore
of GFP is formed by post-translational auto-cyclization of
Ser65, Tyr66, and Gly67 following oxidation. This conforma-
tional change requires no substrate(s) or cofactor(s). There-
fore, GFP can be £uorescent even when expressed in heterol-
ogous species. After the formation of £uorophore that locates
in the center of a barrel-like basket composed of 11 L-sheets
[2], GFP becomes quite stable and remains £uorescent up to
65‡C, pH 11, 1% SDS or 6 M guanidinium chloride [3^5].
Since the ¢rst report of expression of GFP in Caenorhabdi-
tis elegans [6], this novel and simple reporter has attracted
much interest for its potential as an in vivo marker of gene
expression, because other reporter genes that are used fre-
quently encode enzymes, e.g. L-galactosyltransferase (lacZ),
chloramphenicol acetyltransferase (CAT), and ¢re£y lucifer-
ase (luc), and require substrates to detect the gene expression.
Recently, several substrates have been developed that pene-
trate the plasma membrane and are processed in the cyto-
plasm for use in living cells [7]. However, it is still necessary
to load the substrate with these markers. In this context, GFP
has a signi¢cant advantage over other commonly used report-
ers. Since GFP emits green £uorescence without any sub-
strates or cofactors, one can monitor the presence of GFP
by illuminating living cells. GFP may open the door for the
use of intact cells and organisms as experimental systems
[4,5,8]. Here we describe our trials in expressing GFP in a
transgenic mouse system and give an overview of the applica-
tion of GFP as a vital marker in mammals.
2. ‘Dark’ ages
Wild-type GFP used in the early reports was not as bright
as mutant GFPs available today. The emission spectrum of
wild-type (wt) GFP (maximum at 508 nm) is proportional to
that of the well-known dye £uorescein isothiocyanate (FITC;
maximum at 515 nm), but its excitation spectrum (maximum
at 395 nm) di¡ers considerably from that of FITC (maximum
at 493.5 nm). Therefore, a special ¢lter set is necessary for
optimized observation. Moreover, it was reported that the
formation of the wt-GFP chromophore takes a while (about
4 h at 22‡C [9]), and this makes it di⁄cult to determine the
exact point at which gene expression begins. Although cultur-
ing at a low temperature (30^33‡C) facilitates chromophore
formation [10], this presents obvious problems in using the
GFP in culturing mammalian cells and in transgenic mice.
Our ¢rst trial in expressing GFP in transgenic mouse lines
was performed using elongation factor 1 promoter [11]. De-
spite its reputation of ubiquitous expression ability, weak
green £uorescence was observed only in livers of several trans-
genic mouse lines. We then used the CAG promoter, which
was composed of the CMV enhancer, a fragment of the chick-
en L-actin promoter and rabbit L-globin exons [12]. Wild-type
GFP was ampli¢ed by PCR to introduce Kozac sequence and
the EcoRI fragment of the PCR product covering the coding
sequence was inserted into the vector. Using this construct, we
could produce a ¢rst version of the transgenic ‘green mouse’
lines [13]. In all of the transgenic lines produced, muscle and
pancreas were bright green £uorescent as a rule (more than 20
lines were produced). It was possible to tell the transgenic
pups on the day of birth. We even could separate the trans-
genic embryos in their preimplantation stages [14].
On the other hand, brain and blood vessels always re-
mained negative. With this construct, kidney was one of the
GFP expressing organs. However, renal tubules, arteries and
interstitium were always silent in GFP expression and only
glomeruli becomes green £uorescent. To con¢rm the cellular
localization in the glomerulus, glomerular basement mem-
brane (GBM) was stained with laminin antibody. When
GFP was stained with rhodamine conjugated antibody, the
GFP positive cells were determined as podocytes, which
were present just outside the GBM. The podocyte speci¢c
expression with the CAG promoter in kidney was also a
rule without exceptions among many transgenic mouse lines
that expressed GFP. Transgenic human CD4 expressed with
the same promoter was also limited in the glomerular region
in the kidney. Therefore, we thought the vector could be used
as a podocyte oriented expression promoter [15]. However, to
our surprise, we found a very di¡erent expression pattern
when we used mutant GFP as a coding sequence in the
same vector.
3. Mutant GFPs
Recently, genetically engineered GFPs have been reported
to show di¡erent characteristics such as spectra, magnitude,
solubility, etc. [9,16,17]. Many of the GFP variants contain
mutations within the chromophore region itself. Replacement
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of Ser65 by Thr (S65T) shifts the excitation spectrum to a
slightly longer wavelength (maximum at 489 nm) and results
in optimal spectra for observation with FITC ¢lter sets or for
analysis using £ow cytometry [18]. The S65T mutant was also
reported to form a chromophore about four times more rap-
idly than wt-GFP [18]. Some mutations were reported to im-
prove the thermosensitivity of GFP [19,20]. The double amino
acid substitutions (P64L and S65T) in GFPmut1 (EGFP)
caused about 35-fold brighter £uorescence compared to wt-
GFP due to an increase in its extinction coe⁄cient (EM) [17].
To date, various GFPs not only emitting green but also blue
(BFP) or yellow (YFP) £uorescence have been created. With
or without mutation, GFP can emit red £uorescence with
green excitation under conditions of low oxygen [21]. This
implies that a £uorescent protein emitting red £uorescence
might also be available in the near future. Combining these
variants, the separation of speci¢c GFP expressing cells is
possible (Fig. 1). The characteristics of GFP and its typical
variants are listed in Table 1.
4. Ubiquitous ‘green mice’
We kept producing ‘green mice’ in an attempt to have the
GFP transgene integrated in the sex chromosome. Meanwhile,
as described in Section 3, various mutants with characteristic
natures have appeared and we always used a newer and
brighter version of GFP to make ‘green mice’. We found no
di¡erence when we switched from wt-GFP to RS-GFP (not
listed in Table 1 but similar to S65T) [22] in the expression
pattern except the latter has brighter £uorescence. However,
to our surprise, when EGFP was expressed using the same
CAG promoter, all the organs of all the transgenic mouse
lines were uniformly green with a few exception of hair and
red blood cells. The brain, liver, kidney, adrenal gland, lung,
muscle, heart, intestine, adipose tissue, thymus, spleen and
testicular cells of all transgenic mouse lines were naturally
green when irradiated with excitation light [23]. Since a
matching of genetic background is important, we have also
recently produced a ubiquitous ‘green mice’ with C57BL/6
background. The mice are available to the scienti¢c ¢eld
upon request.
In jelly¢sh, GFP is normally sequestered in microbody-like
lumisomes. However, in the transgenic experiment described
here, the EGFP was designed to be expressed in the cytosol
and the soluble nature of the protein allowed its distribution
throughout the cytosol. This situation could cause a toxic
e¡ect if EGFP were expressed at high levels. However, all
of the transgenic mouse lines looked normal and healthy,
despite a signi¢cant amount of EGFP expression throughout
the body. The expression of GFP therefore seemed to be non-
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Fig. 1. Eggs labeled with wt-GFP or RS-GFP were distinguishable by shedding the di¡erent excitation light. The eggs expressing wt-GFP emit
green when excited with V-¢lter sets (middle), while RS-GFP expressing eggs (right) are £uorescent with B-¢lter sets.
Table 1
GFP and its variants
Variant Mutation Max.
excitation
Max.
emission
EM
(cm31 M31)
Characteristics Reference
Wild-type
GFP ^ 395 509 21 000 (7150) green emission [6]
S65T S65T 489 511 39 200 excited at 488 nm [18]
GFPmut1 (EGFP) F64L, S65T 488 507 250 000 35 times brighter [17]
P4-3 (BFP) Y66H, Y145P 380 440 37 000 blue emission [9]
10C (YFP) S65G, V68L, S72A, T203Y 513 527 36 500 greenish-yellow emission [2]
The EM was measured at optimal excitation. The EM for 488 nm excitation of wt-GFP is presented in parentheses. There is an informative table
listing GFP variants and many of them are commercially available: http://www.image1.com/.
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toxic. These results indicate that EGFP could be used as a
novel reporter in almost the whole mouse body from pre-
implantation stage to adulthood.
The di¡erence was not simply due to greater sensitivity of
EGFP, allowing detection in tissues with lower expression.
For example, while blood vessels were always negative in
transgenic mice expressing wt-GFP, this tissue was one of
the brightest parts of the body in more than 50 lines of all
the transgenic animals expressing EGFP. Since the di¡erence
between EGFP structure and others is only a few amino acid
substitutions, codon optimization must be responsible for the
ubiquitous expression. However, as indicated earlier, with a
combination of human CD4 cDNA, the CAG promoter did
not serve as a ubiquitous promoter. The real cause of the
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Fig. 2. ‘Green sperm’. The sperm from the acrosin-GFP transgenic mouse lines had a green £uorescent acrosome. The sperm in the photo are
not stained but naturally ‘green £uorescent’ under appropriate excitation light. Therefore we could observe ‘green sperm’ swimming under the
microscope and interacting with eggs.
Fig. 3. A female pup from one of our X-linked transgenic ‘green mice’. Although the GFP transgene should be distributed all over the body as
hemizygous transgenic mouse, only half of the body surface glows ‘green’, probably because half of the X chromosome carrying the transgene
has become silent by X inactivation. The photo was taken under a Leica stereotype £uorescein microscope under normal lighting together with
GFP excitation lighting. As shown in the photo, the green £uorescence was strong enough to observe in a bright environment.
M. Ikawa et al./FEBS Letters 430 (1998) 83^87 85
di¡erent expression pattern with di¡erent coding sequence
remains to be solved.
5. Green sperm and others
In contrast to ubiquitous expression, cell or organ speci¢c
expression of GFP is also possible if we use an appropriate
promoter to drive GFP in transgenic mice and the fusion with
a signal peptide leads GFP to the target organelle. The use of
the acrosin promoter enabled male germ cell speci¢c expres-
sion. When the amino-terminus of EGFP was fused at the
carboxy-terminus of the acrosin signal peptide, the £uores-
cence localized inside the sperm acrosome. Sperm need to
cause vesiculation of the acrosome before acquiring fertilizing
ability. This phenomenon is known as the acrosome reaction,
which occurs in the female reproductive tract and it has been
extensively studied in mice. In order to detect the change in
acrosome, antibodies, £uorescent dye, and agglutinins have
been utilized. The green sperm we made would serve as a
convenient tool to monitor the acrosomal status non-inva-
sively Fig. 2.
The visualization of astrocytes was achieved by astrocyte
speci¢c glial ¢brillary acidic protein (GFAP) promoter. Ac-
cording to their comparison, GFP served better than lacZ in
terms of mimicking the GFAP expression pattern, suggesting
a possibility of interference of gene expression by the lacZ
sequence [24].
6. GFP as a transgenic marker
The main methods used in detection of transgenes are PCR
analysis or Southern blotting following extraction of DNA
from the tails of 3^4 week old pups [25]. However, the pro-
cedures require skill and consume time if applied to a large
number of transgenic animals. Since the ‘green mice’ are dis-
tinguishable by their green £uorescence when they are born,
the pCX-GFPs is useful as a transgenic marker when co-in-
jected with a desired transgene. When the GFP gene was in-
jected with a target gene (molar ratio; 1:1), more than 80% of
transgenic founder mice carried both genes, while the remain-
ing 20% carried one (Okabe et al., unpublished data).
GFP expressing constructs can be used for the e⁄cient pro-
duction of transgenic animals. To date, the low e⁄ciency of
transgenic animal production by microinjection has been a
serious problem, especially in large mammals. Using GFP as
a reporter gene, it was shown that eggs injected at the pronu-
clear stage become £uorescent until the blastocyst stage and
transgenic eggs can be selected in a considerably high ratio
before implantation [26].
After the production of the founder transgenic animals, it
would be necessary to propagate the transgenic animals.
However, animals such as bovine need a long gestation period
and the number of o¡spring is limited. If the preimplantation
stage transgenic embryos could be selected after in vitro fer-
tilization using sperm from a transgenic founder male with
eggs from a wild-type female, the e⁄ciency of transgenic ani-
mal expansion would be greatly improved. As shown in the
experiment using transgenic mice, it was shown to be easy to
separate transgenic eggs before the implantation stage accord-
ing to the green £uorescence from transgenic eggs. Many
mixed transgenic and non-transgenic embryos were separated
under £uorescent microscope and subjected to PCR analysis
and the separation was con¢rmed to be accurate. When sep-
arated embryos were transferred into the uterus of pseudo-
pregnant females (day 2.5), all the mice born from green eggs
proved to be carrying the GFP transgene while the non-green
eggs did not carry the transgene at all [14]. These data imply
that an e⁄cient production and propagation of transgenic
livestock could be achieved by GFP co-injection.
Recently, embryo sexing by PCR analysis from a part of
the embryo has been performed in a variety of species such as
human, bovine and mouse [27,28]. However, if we could pro-
duce ‘green mice’ that have the GFP transgene on the sex
chromosome, the ‘green eggs’ represent male (or female) em-
bryos depending on the incorporated sex chromosome. We
have so far produced 1^5 transgenic mouse lines for each of
the chromosomes 1^19, X and Y with a genetic background
of B6C3F1 mice. The photo in Fig. 3 shows a ‘green mouse’
with the GFP transgene integrated in the X chromosome.
Half of the skin was green and the rest was not green due
to X-inactivation (Okabe, in preparation).
Since the ¢rst report of GFP as a marker protein, this new
probe has been providing us with numerous new experimental
methods. The unprecedented nature of this GFP challenges us
to ¢nd brand new uses for the protein. GFP fusion proteins,
‘chameleons’, which measure Ca2 concentration, are one of
the examples for new GFP usage. In the future, we need to
keep our eyes not only on brighter mutant GFPs, but also on
innovative uses for this vital marker.
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